Press "Enter" to skip to content

Basilea starts phase 1/2 study with derazantinib in urothelial cancer – StreetInsider.com

admin 0

Basilea starts phase 1/2 study with derazantinib in urothelial cancer  StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Basel, Switzerland, August 13, 2019 – Basilea …

“bladder cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *